Variant report
Variant | nsv1028715 |
---|---|
Chromosome Location | chr9:7505178-7516672 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529077138 | chr9:7506610-7506611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201566681 | chr9:7506698-7506699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557448825 | chr9:7506699-7506700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549087747 | chr9:7506713-7506714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192389356 | chr9:7506721-7506722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559678221 | chr9:7506724-7506725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369716799 | chr9:7506745-7506746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79746248 | chr9:7506760-7506761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564527984 | chr9:7506762-7506763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535909377 | chr9:7506770-7506771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141602869 | chr9:7506795-7506796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550235957 | chr9:7506835-7506836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181780142 | chr9:7506851-7506852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373822633 | chr9:7506856-7506857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535652403 | chr9:7506858-7506859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs117088428 | chr9:7506877-7506878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs117480959 | chr9:7506937-7506938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147091338 | chr9:7506951-7506952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148150231 | chr9:7506972-7506973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575976486 | chr9:7506989-7506990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186138809 | chr9:7506990-7506991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76197569 | chr9:7506997-7506998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79992156 | chr9:7507018-7507019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555436493 | chr9:7507025-7507026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75705931 | chr9:7507083-7507084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541188226 | chr9:7507094-7507095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559592524 | chr9:7507119-7507120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577978808 | chr9:7507138-7507139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371059366 | chr9:7507139-7507140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576597917 | chr9:7507162-7507163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374187560 | chr9:7507165-7507166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545303614 | chr9:7507166-7507167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12340314 | chr9:7507190-7507191 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs531712798 | chr9:7507216-7507217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs377448493 | chr9:7507217-7507218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190810480 | chr9:7507219-7507220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183037696 | chr9:7507233-7507234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs75848697 | chr9:7507239-7507240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs17613477 | chr9:7507284-7507285 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs75463245 | chr9:7507322-7507323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs368438610 | chr9:7507323-7507324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371652182 | chr9:7507354-7507355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552028778 | chr9:7507384-7507385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570300232 | chr9:7507403-7507404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537039669 | chr9:7507410-7507411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555412555 | chr9:7507473-7507474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374961420 | chr9:7507483-7507484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372031396 | chr9:7507507-7507508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs573732088 | chr9:7507518-7507519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188364068 | chr9:7507546-7507547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:7506600-7508200 | Enhancers | Fetal Heart | heart |
2 | chr9:7507000-7511400 | Enhancers | Fetal Lung | lung |
3 | chr9:7507400-7507800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr9:7507600-7508200 | Enhancers | Left Ventricle | heart |
5 | chr9:7507800-7509600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr9:7508200-7510200 | Weak transcription | Left Ventricle | heart |
7 | chr9:7509800-7510000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr9:7509800-7510000 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr9:7509800-7510000 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr9:7510000-7510200 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
11 | chr9:7510000-7510200 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr9:7510000-7510400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr9:7510000-7510600 | Enhancers | Ovary | ovary |
14 | chr9:7510200-7510400 | Flanking Bivalent TSS/Enh | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr9:7510200-7510400 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr9:7510200-7510400 | Enhancers | Left Ventricle | heart |
17 | chr9:7510400-7510600 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
18 | chr9:7510400-7510800 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
19 | chr9:7511000-7511200 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
20 | chr9:7511400-7511800 | Weak transcription | Fetal Lung | lung |
21 | chr9:7511800-7512000 | Enhancers | Fetal Lung | lung |
22 | chr9:7512000-7515800 | Weak transcription | Fetal Lung | lung |
23 | chr9:7514600-7515600 | Enhancers | Fetal Heart | heart |
24 | chr9:7515800-7517200 | Enhancers | Fetal Lung | lung |
25 | chr9:7516200-7516800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
26 | chr9:7516200-7517000 | Enhancers | Cortex derived primary cultured neurospheres | brain |